• Posted: January 28, 2016 Elotuzumab in combination with lenalidomide and dexamethasone in patients with...

    Richardson PG, Jagannath S, Moreau P, Jakubowiak AJ, Raab MS, Facon T, Vij R, White D, Reece DE, Benboubker L, Zonder J, Tsao LC, Anderson KC, Bleickardt E,...

    READ MORE
  • Posted: January 28, 2016 Proteomic characterization of circulating extracellular vesicles identifies...

    Harshman SW, Canella A, Ciarlariello PD, Agarwal K, Branson OE, Rocci A, Cordero H, Phelps MA, Hade EM, Dubovsky JA, Palumbo A, Rosko A, Byrd JC, Hofmeister...

    READ MORE
  • Posted: December 15, 2015 Exclusive Q&A with MMRF Board member, Dr. Ken Anderson

    What should patients know about the three recent drug approvals in multiple myeloma? The three recent approvals are a continuation of amazing progress in this...

    READ MORE
  • Posted: November 30, 2015 Statement from Walter M. Capone, President and CEO of the Multiple Myeloma...

    "The approval of elotuzumab marks another important milestone in the treatment of multiple myeloma in a short period of time. Since 2008, the Multiple Myeloma...

    READ MORE
  • Posted: November 20, 2015 Statement from Walter M. Capone, President and CEO of the Multiple Myeloma...

    “The field of cancer treatment, and multiple myeloma in particular, has never seen a watershed moment like this. With two breakthrough designation drug...

    READ MORE
  • Posted: November 19, 2015 American Society of Blood and Marrow Transplantation, European Society of Blood...

    Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B, Hari P, Lokhorst H, McCarthy P, Krishnan A, Sonneveld P, Goldschmidt H, Jagannath S, Barlogie B,...

    READ MORE
  • Posted: November 19, 2015 A Phase 2 Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2...

    Holkova B, Zingone A, Kmieciak M, Bose P, Badros AZ, Voorhees PM, Baz R, Korde N, Lin HY, Chen JQ, Herrmann MA, Xi L, Raffeld M, Zhao X, Wan W, Tombes MB,...

    READ MORE
  • Posted: November 19, 2015 Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.

    Kokonozaki M, Tsirakis G, Devetzoglou M, Kyriakaki S, Antonakis A, Vyzoukaki R, Pappa CA, Tzardi M, Alexandrakis MG. Leuk Res. 2015 Oct 20. pii:...

    READ MORE
  • Posted: November 19, 2015 The Proteasome Inhibitor, Bortezomib, Maintains Osteocyte Viability in Multiple...

    Toscani D, Palumbo C, Dalla Palma B, Ferretti M, Bolzoni M, Marchica V, Sena P, Martella E, Mancini C, Ferri V, Costa F, Accardi F, Craviotto L, Aversa F,...

    READ MORE
  • Posted: November 19, 2015 Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor...

    Shah JJ, Jakubowiak AJ, O'Connor OA, Orlowski RZ, Harvey RD, Smith MR, Lebovic D, Diefenbach C, Kelly K, Hua Z, Berger AJ, Mulligan G, Faessel HM, Tirrell S,...

    READ MORE

Page 12/15